GLP-1 balance describes the optimal production and function of glucagon-like peptide-1, a hormone that regulates blood sugar and appetite
This slow-down in digestion can lead to more gastrointestinal side effects, such as nausea, diarrhea, constipation, and, of course, burping
Weiss NS, Kostova E, Nahuis M, Mol BWJ, van der Veen F, van Wely M
GLP-1 supply constraints limited market growth 20222024: Novo Nordisk and Eli Lilly both experienced significant supply constraints limiting GLP-1 prescription fulfilment, particularly Wegovy

Choose injectable GLP-1s if: Maximum weight loss is your primary goal You want proven, consistent results backed by extensive clinical trials Weekly dosing fits better into your routine than daily medication You have absorption issues or take other morning medications Cost is a concern (compounded injectables are most affordable) You value the gold standard with predictable outcomes Consider FDA-approved oral tablets if: You're extremely needle-averse and won't use injections You have modest weight loss goals You can maintain a strict morning medication routine with 30-minute fasting You prefer FDA-approved medications over compounded options You don't mind the lower bioavailability and the need for higher doses Consider compounded ODT formulations if: You're needle-averse but want to avoid swallowing pills You're willing to try an emerging option without clinical validation You can afford the higher cost compared to compounded injectables You're comfortable with daily dosing For most people seeking significant weight loss, injectable GLP-1 medications currently offer superior results, better convenience (despite being injections), and more cost-effective options through oral options
